Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphedema | 41 | 2024 | 525 | 11.980 |
Why?
|
Vascular Malformations | 31 | 2024 | 470 | 8.300 |
Why?
|
Arteriovenous Malformations | 16 | 2023 | 397 | 6.440 |
Why?
|
Hemangioma | 25 | 2023 | 724 | 5.160 |
Why?
|
Lymphatic Vessels | 10 | 2022 | 356 | 3.480 |
Why?
|
Bone Transplantation | 14 | 2016 | 920 | 2.790 |
Why?
|
MAP Kinase Kinase 1 | 5 | 2023 | 330 | 2.470 |
Why?
|
Lymphatic Abnormalities | 10 | 2018 | 134 | 2.470 |
Why?
|
Parietal Bone | 7 | 2016 | 49 | 2.260 |
Why?
|
Lipectomy | 5 | 2021 | 114 | 2.000 |
Why?
|
Capillaries | 7 | 2024 | 751 | 1.880 |
Why?
|
Skull | 10 | 2014 | 818 | 1.790 |
Why?
|
Lipomatosis | 5 | 2017 | 112 | 1.750 |
Why?
|
Frontal Bone | 9 | 2016 | 105 | 1.750 |
Why?
|
Lower Extremity | 13 | 2021 | 1219 | 1.670 |
Why?
|
Sturge-Weber Syndrome | 6 | 2024 | 87 | 1.650 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2021 | 1763 | 1.640 |
Why?
|
Endothelial Cells | 17 | 2024 | 3586 | 1.610 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 7 | 2020 | 904 | 1.600 |
Why?
|
Craniotomy | 11 | 2016 | 737 | 1.520 |
Why?
|
Hemangioma, Capillary | 5 | 2018 | 63 | 1.410 |
Why?
|
Facial Neoplasms | 3 | 2016 | 126 | 1.280 |
Why?
|
Skin Neoplasms | 13 | 2019 | 5836 | 1.250 |
Why?
|
Craniosynostoses | 8 | 2014 | 415 | 1.150 |
Why?
|
Arteriovenous Fistula | 2 | 2021 | 318 | 1.140 |
Why?
|
Mutation | 25 | 2023 | 30192 | 1.120 |
Why?
|
Skin Transplantation | 5 | 2020 | 1097 | 1.110 |
Why?
|
Receptors, FSH | 2 | 2018 | 29 | 1.050 |
Why?
|
Obesity | 13 | 2022 | 13082 | 1.020 |
Why?
|
Vascular Neoplasms | 3 | 2018 | 167 | 1.010 |
Why?
|
Hemangioendothelioma | 3 | 2017 | 112 | 0.990 |
Why?
|
Ear, External | 3 | 2020 | 164 | 0.970 |
Why?
|
Neoplasms, Vascular Tissue | 2 | 2018 | 25 | 0.960 |
Why?
|
Infant | 57 | 2023 | 36426 | 0.910 |
Why?
|
Face | 7 | 2017 | 1029 | 0.910 |
Why?
|
Facial Bones | 3 | 2012 | 209 | 0.910 |
Why?
|
Abnormalities, Multiple | 6 | 2020 | 1424 | 0.860 |
Why?
|
GTP-Binding Protein alpha Subunits | 3 | 2023 | 103 | 0.850 |
Why?
|
Nevus, Pigmented | 2 | 2015 | 222 | 0.820 |
Why?
|
Osteogenesis | 7 | 2021 | 1281 | 0.820 |
Why?
|
Extremities | 5 | 2017 | 868 | 0.820 |
Why?
|
Surgical Flaps | 6 | 2020 | 1678 | 0.810 |
Why?
|
Child, Preschool | 55 | 2023 | 42510 | 0.810 |
Why?
|
Nose Neoplasms | 3 | 2015 | 249 | 0.800 |
Why?
|
Receptor, TIE-2 | 2 | 2024 | 183 | 0.790 |
Why?
|
Child | 71 | 2023 | 80568 | 0.780 |
Why?
|
Basketball | 1 | 2021 | 43 | 0.760 |
Why?
|
Upper Extremity | 5 | 2019 | 681 | 0.750 |
Why?
|
Receptor, EphB4 | 1 | 2021 | 39 | 0.740 |
Why?
|
Humans | 186 | 2024 | 765926 | 0.720 |
Why?
|
Hockey | 1 | 2021 | 96 | 0.720 |
Why?
|
Adolescent | 60 | 2021 | 88811 | 0.710 |
Why?
|
X-Ray Microtomography | 5 | 2012 | 454 | 0.670 |
Why?
|
Ear Auricle | 2 | 2020 | 31 | 0.660 |
Why?
|
Neovascularization, Pathologic | 5 | 2021 | 2627 | 0.660 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.660 |
Why?
|
Veins | 3 | 2016 | 768 | 0.650 |
Why?
|
Sclerotherapy | 7 | 2021 | 184 | 0.650 |
Why?
|
Male | 112 | 2024 | 363815 | 0.630 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 6 | 2024 | 148 | 0.630 |
Why?
|
Referral and Consultation | 3 | 2020 | 3615 | 0.630 |
Why?
|
Wounds and Injuries | 4 | 2015 | 2513 | 0.620 |
Why?
|
Hypertrophy | 7 | 2017 | 562 | 0.610 |
Why?
|
Cartilage Diseases | 1 | 2020 | 159 | 0.600 |
Why?
|
Dura Mater | 3 | 2016 | 295 | 0.600 |
Why?
|
Female | 104 | 2024 | 396141 | 0.590 |
Why?
|
Propranolol | 2 | 2017 | 494 | 0.590 |
Why?
|
Neuromuscular Diseases | 1 | 2020 | 260 | 0.580 |
Why?
|
ras Proteins | 2 | 2020 | 1054 | 0.580 |
Why?
|
Head and Neck Neoplasms | 4 | 2014 | 2924 | 0.580 |
Why?
|
Young Adult | 38 | 2021 | 59857 | 0.570 |
Why?
|
Liver Regeneration | 5 | 2008 | 213 | 0.570 |
Why?
|
Sarcoma, Kaposi | 2 | 2017 | 376 | 0.570 |
Why?
|
Terminology as Topic | 5 | 2015 | 1536 | 0.560 |
Why?
|
Leg | 2 | 2019 | 1088 | 0.550 |
Why?
|
Parotid Neoplasms | 3 | 2017 | 157 | 0.540 |
Why?
|
Wound Healing | 7 | 2015 | 2794 | 0.540 |
Why?
|
Beckwith-Wiedemann Syndrome | 1 | 2016 | 45 | 0.540 |
Why?
|
Hepatectomy | 5 | 2008 | 588 | 0.530 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2019 | 360 | 0.530 |
Why?
|
Adrenal Cortex Hormones | 5 | 2015 | 1881 | 0.520 |
Why?
|
Leg Injuries | 2 | 2021 | 180 | 0.520 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2015 | 249 | 0.520 |
Why?
|
Follicle Stimulating Hormone | 1 | 2018 | 731 | 0.510 |
Why?
|
Dermabrasion | 1 | 2015 | 17 | 0.510 |
Why?
|
Body Mass Index | 9 | 2021 | 13042 | 0.510 |
Why?
|
Hydroquinones | 1 | 2015 | 34 | 0.510 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 89 | 0.500 |
Why?
|
Suture Techniques | 3 | 2015 | 774 | 0.500 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 704 | 0.490 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1239 | 0.490 |
Why?
|
Telangiectasis | 1 | 2015 | 77 | 0.490 |
Why?
|
Lymphangiosarcoma | 1 | 2015 | 14 | 0.490 |
Why?
|
MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.490 |
Why?
|
Skin Diseases, Vascular | 1 | 2015 | 41 | 0.490 |
Why?
|
Myofibroma | 2 | 2018 | 45 | 0.480 |
Why?
|
Surgery, Plastic | 3 | 2008 | 652 | 0.470 |
Why?
|
Rabbits | 8 | 2016 | 4729 | 0.470 |
Why?
|
Facial Dermatoses | 1 | 2015 | 87 | 0.470 |
Why?
|
Epinephrine | 3 | 2010 | 782 | 0.470 |
Why?
|
Bone Regeneration | 3 | 2012 | 436 | 0.470 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2017 | 1238 | 0.460 |
Why?
|
Subcutaneous Tissue | 4 | 2021 | 131 | 0.460 |
Why?
|
Vasoconstrictor Agents | 2 | 2010 | 653 | 0.460 |
Why?
|
Triamcinolone | 1 | 2014 | 68 | 0.460 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1258 | 0.450 |
Why?
|
Blood Vessels | 2 | 2012 | 1113 | 0.450 |
Why?
|
Tissue and Organ Harvesting | 5 | 2014 | 373 | 0.450 |
Why?
|
Adult | 50 | 2024 | 223088 | 0.450 |
Why?
|
Subcutaneous Fat | 1 | 2017 | 401 | 0.440 |
Why?
|
Arm Injuries | 2 | 2012 | 156 | 0.440 |
Why?
|
Granuloma, Pyogenic | 3 | 2020 | 47 | 0.430 |
Why?
|
Cicatrix | 2 | 2016 | 796 | 0.420 |
Why?
|
Mastectomy | 2 | 2024 | 1848 | 0.420 |
Why?
|
Inlays | 1 | 2012 | 8 | 0.410 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.410 |
Why?
|
Glucocorticoids | 4 | 2017 | 2155 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 18074 | 0.400 |
Why?
|
Ear, Middle | 1 | 2014 | 341 | 0.390 |
Why?
|
Receptors, Somatotropin | 1 | 2012 | 58 | 0.390 |
Why?
|
Cheek | 1 | 2011 | 65 | 0.380 |
Why?
|
Bone Resorption | 2 | 2012 | 717 | 0.380 |
Why?
|
Dermatologic Agents | 1 | 2015 | 314 | 0.370 |
Why?
|
Infant, Newborn | 24 | 2023 | 26380 | 0.370 |
Why?
|
Down Syndrome | 2 | 2011 | 915 | 0.370 |
Why?
|
Pilomatrixoma | 1 | 2011 | 24 | 0.370 |
Why?
|
Transplantation, Autologous | 6 | 2014 | 2125 | 0.360 |
Why?
|
Phenotype | 6 | 2021 | 16714 | 0.360 |
Why?
|
Compartment Syndromes | 1 | 2012 | 159 | 0.350 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1621 | 0.350 |
Why?
|
Hair Diseases | 1 | 2011 | 73 | 0.350 |
Why?
|
Diagnosis, Differential | 11 | 2020 | 12973 | 0.350 |
Why?
|
Prednisolone | 1 | 2011 | 323 | 0.350 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2011 | 67 | 0.350 |
Why?
|
Diagnostic Errors | 5 | 2017 | 1276 | 0.340 |
Why?
|
Meningomyelocele | 1 | 2012 | 182 | 0.340 |
Why?
|
Bone Substitutes | 2 | 2012 | 229 | 0.340 |
Why?
|
Menopause | 1 | 2018 | 1659 | 0.340 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2011 | 462 | 0.340 |
Why?
|
Age of Onset | 5 | 2024 | 3343 | 0.340 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2053 | 0.340 |
Why?
|
Postoperative Complications | 10 | 2024 | 15802 | 0.340 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 2 | 2015 | 69 | 0.330 |
Why?
|
Tissue Engineering | 2 | 2021 | 1857 | 0.320 |
Why?
|
Disease Management | 2 | 2019 | 2530 | 0.320 |
Why?
|
Exercise Therapy | 1 | 2016 | 936 | 0.320 |
Why?
|
Ear Diseases | 1 | 2011 | 179 | 0.320 |
Why?
|
Lymphatic System | 2 | 2021 | 250 | 0.310 |
Why?
|
Matrix Metalloproteinase 9 | 3 | 2011 | 636 | 0.310 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15878 | 0.310 |
Why?
|
Prostheses and Implants | 2 | 2017 | 1273 | 0.300 |
Why?
|
Methylmethacrylates | 1 | 2008 | 64 | 0.300 |
Why?
|
Wilms Tumor | 2 | 2017 | 378 | 0.300 |
Why?
|
Siblings | 1 | 2012 | 828 | 0.300 |
Why?
|
Breast | 6 | 2017 | 1950 | 0.300 |
Why?
|
Nipples | 1 | 2009 | 222 | 0.290 |
Why?
|
Bone Wires | 1 | 2008 | 125 | 0.290 |
Why?
|
Neovascularization, Physiologic | 4 | 2013 | 1370 | 0.290 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 3360 | 0.290 |
Why?
|
Signal Transduction | 6 | 2021 | 23597 | 0.290 |
Why?
|
Fibroma | 1 | 2009 | 197 | 0.290 |
Why?
|
Skull Neoplasms | 1 | 2008 | 173 | 0.280 |
Why?
|
Family Health | 1 | 2012 | 1253 | 0.280 |
Why?
|
Adiposity | 1 | 2017 | 1891 | 0.280 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1152 | 0.280 |
Why?
|
Nevus | 2 | 2021 | 204 | 0.280 |
Why?
|
Polymerase Chain Reaction | 5 | 2021 | 6058 | 0.280 |
Why?
|
Scalp Dermatoses | 1 | 2007 | 44 | 0.270 |
Why?
|
Orbit | 3 | 2010 | 458 | 0.270 |
Why?
|
Middle Aged | 28 | 2024 | 223016 | 0.270 |
Why?
|
Body Image | 3 | 2017 | 645 | 0.270 |
Why?
|
Self Concept | 4 | 2017 | 1039 | 0.270 |
Why?
|
Neurocutaneous Syndromes | 1 | 2007 | 53 | 0.260 |
Why?
|
Alleles | 4 | 2021 | 6891 | 0.260 |
Why?
|
Retrospective Studies | 30 | 2024 | 81537 | 0.260 |
Why?
|
Embolization, Therapeutic | 3 | 2011 | 1405 | 0.260 |
Why?
|
Thigh | 1 | 2007 | 236 | 0.250 |
Why?
|
Weight Loss | 3 | 2021 | 2710 | 0.250 |
Why?
|
Receptors, Androgen | 1 | 2012 | 1086 | 0.250 |
Why?
|
DNA Mutational Analysis | 4 | 2019 | 4111 | 0.250 |
Why?
|
Craniofacial Abnormalities | 1 | 2008 | 320 | 0.250 |
Why?
|
Statistics, Nonparametric | 5 | 2011 | 2844 | 0.240 |
Why?
|
DNA | 2 | 2016 | 7193 | 0.240 |
Why?
|
Phlebotomy | 1 | 2005 | 138 | 0.240 |
Why?
|
Suction | 2 | 2016 | 268 | 0.240 |
Why?
|
Treatment Outcome | 24 | 2020 | 65194 | 0.240 |
Why?
|
Hamartoma | 1 | 2007 | 235 | 0.240 |
Why?
|
Anti-Inflammatory Agents | 2 | 2011 | 1802 | 0.240 |
Why?
|
Receptor, TIE-1 | 1 | 2024 | 13 | 0.240 |
Why?
|
Follow-Up Studies | 15 | 2017 | 39228 | 0.230 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2004 | 71 | 0.230 |
Why?
|
Finger Injuries | 2 | 2007 | 145 | 0.230 |
Why?
|
Mammaplasty | 4 | 2024 | 1264 | 0.230 |
Why?
|
Median Nerve | 1 | 2005 | 131 | 0.230 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 150 | 0.230 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 2242 | 0.220 |
Why?
|
Lip | 2 | 2018 | 196 | 0.220 |
Why?
|
Disease Progression | 8 | 2015 | 13614 | 0.220 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4423 | 0.220 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 392 | 0.220 |
Why?
|
Ketorolac | 1 | 2024 | 95 | 0.220 |
Why?
|
Fingers | 2 | 2012 | 509 | 0.220 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.210 |
Why?
|
Cerebral Palsy | 1 | 2008 | 481 | 0.210 |
Why?
|
Stem Cells | 2 | 2018 | 3537 | 0.210 |
Why?
|
Models, Educational | 1 | 2006 | 375 | 0.210 |
Why?
|
Facial Asymmetry | 3 | 2009 | 173 | 0.210 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2015 | 86 | 0.200 |
Why?
|
Computer-Assisted Instruction | 1 | 2006 | 368 | 0.200 |
Why?
|
Genital Diseases, Male | 2 | 2014 | 84 | 0.200 |
Why?
|
Aged | 17 | 2021 | 171163 | 0.200 |
Why?
|
Osteoblasts | 3 | 2012 | 1143 | 0.200 |
Why?
|
Animals | 29 | 2024 | 168735 | 0.200 |
Why?
|
Neuroblastoma | 1 | 2010 | 1264 | 0.200 |
Why?
|
Biopsy | 3 | 2017 | 6766 | 0.190 |
Why?
|
p120 GTPase Activating Protein | 1 | 2021 | 35 | 0.190 |
Why?
|
Axilla | 2 | 2020 | 615 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.190 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.190 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 646 | 0.190 |
Why?
|
Iatrogenic Disease | 1 | 2005 | 551 | 0.190 |
Why?
|
Intestinal Obstruction | 1 | 2005 | 433 | 0.190 |
Why?
|
Career Choice | 1 | 2008 | 769 | 0.190 |
Why?
|
Lower Extremity Deformities, Congenital | 1 | 2021 | 12 | 0.190 |
Why?
|
Syndrome | 4 | 2022 | 3271 | 0.180 |
Why?
|
Toes | 2 | 2021 | 209 | 0.180 |
Why?
|
Tissue Preservation | 2 | 2012 | 170 | 0.180 |
Why?
|
Gynecomastia | 2 | 2013 | 87 | 0.180 |
Why?
|
Ischemia | 2 | 2007 | 1901 | 0.180 |
Why?
|
Oral Surgical Procedures | 1 | 2003 | 172 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2015 | 2877 | 0.180 |
Why?
|
Lymph | 1 | 2020 | 78 | 0.180 |
Why?
|
Splenomegaly | 1 | 2001 | 191 | 0.180 |
Why?
|
Combined Modality Therapy | 6 | 2019 | 8522 | 0.180 |
Why?
|
Mice | 18 | 2024 | 81782 | 0.180 |
Why?
|
Syndactyly | 1 | 2021 | 75 | 0.170 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 186 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2744 | 0.170 |
Why?
|
Ear Cartilage | 1 | 2020 | 62 | 0.170 |
Why?
|
Soft Tissue Neoplasms | 1 | 2009 | 1163 | 0.170 |
Why?
|
Neuregulin-1 | 1 | 2021 | 140 | 0.170 |
Why?
|
Mastoid | 1 | 2020 | 100 | 0.170 |
Why?
|
Osseointegration | 2 | 2012 | 269 | 0.170 |
Why?
|
Mutation, Missense | 4 | 2024 | 2589 | 0.170 |
Why?
|
Injections, Intralesional | 2 | 2014 | 280 | 0.170 |
Why?
|
Neurilemmoma | 1 | 2005 | 522 | 0.170 |
Why?
|
Lipodystrophy | 1 | 2001 | 145 | 0.170 |
Why?
|
Splenectomy | 1 | 2001 | 389 | 0.160 |
Why?
|
Bandages | 2 | 2015 | 270 | 0.160 |
Why?
|
Logistic Models | 4 | 2017 | 13273 | 0.160 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1999 | 185 | 0.160 |
Why?
|
Cell Survival | 4 | 2012 | 5745 | 0.160 |
Why?
|
Reoperation | 4 | 2020 | 4308 | 0.160 |
Why?
|
Laparoscopy | 2 | 2001 | 2037 | 0.160 |
Why?
|
Radioactive Tracers | 1 | 2019 | 61 | 0.160 |
Why?
|
DNA, Complementary | 1 | 2022 | 1984 | 0.160 |
Why?
|
Adenoma | 1 | 2009 | 2155 | 0.160 |
Why?
|
Cranial Sutures | 2 | 2010 | 92 | 0.160 |
Why?
|
Sesquiterpenes | 3 | 2004 | 175 | 0.160 |
Why?
|
Temporal Bone | 3 | 2009 | 683 | 0.150 |
Why?
|
Hyperparathyroidism | 1 | 1999 | 338 | 0.150 |
Why?
|
Zygoma | 2 | 2009 | 52 | 0.150 |
Why?
|
Ileum | 1 | 2000 | 558 | 0.150 |
Why?
|
Reference Values | 3 | 2011 | 4909 | 0.150 |
Why?
|
Ultrasonography | 4 | 2017 | 5987 | 0.150 |
Why?
|
Secondary Prevention | 2 | 2016 | 1470 | 0.150 |
Why?
|
Choroid Neoplasms | 1 | 2019 | 175 | 0.140 |
Why?
|
Puberty | 2 | 2012 | 495 | 0.140 |
Why?
|
Immunohistochemistry | 5 | 2012 | 11030 | 0.140 |
Why?
|
Parathyroidectomy | 1 | 1999 | 244 | 0.140 |
Why?
|
Paracrine Communication | 2 | 2021 | 277 | 0.140 |
Why?
|
Students, Medical | 2 | 2008 | 1962 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 389 | 0.140 |
Why?
|
Endothelium | 2 | 2014 | 768 | 0.140 |
Why?
|
History, 19th Century | 3 | 2007 | 711 | 0.140 |
Why?
|
Interferon-alpha | 2 | 2016 | 909 | 0.140 |
Why?
|
Age Distribution | 2 | 2015 | 2864 | 0.140 |
Why?
|
Cleft Palate | 1 | 2003 | 596 | 0.140 |
Why?
|
Sex Distribution | 2 | 2015 | 2269 | 0.140 |
Why?
|
Head | 3 | 2012 | 926 | 0.140 |
Why?
|
Neck | 2 | 2012 | 735 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 548 | 0.130 |
Why?
|
Cohort Studies | 8 | 2019 | 41680 | 0.130 |
Why?
|
Orbital Fractures | 1 | 2017 | 108 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12059 | 0.130 |
Why?
|
Choroid | 1 | 2019 | 351 | 0.130 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2017 | 101 | 0.130 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2008 | 186 | 0.130 |
Why?
|
Prognosis | 4 | 2020 | 29890 | 0.130 |
Why?
|
Sclerosing Solutions | 1 | 2016 | 80 | 0.130 |
Why?
|
Up-Regulation | 3 | 2021 | 4130 | 0.130 |
Why?
|
Base Sequence | 2 | 2017 | 12405 | 0.130 |
Why?
|
Skin Abnormalities | 1 | 2016 | 60 | 0.130 |
Why?
|
Lymphography | 1 | 2016 | 189 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2020 | 551 | 0.120 |
Why?
|
Sulfonamides | 1 | 2005 | 1979 | 0.120 |
Why?
|
Organ Size | 2 | 2019 | 2261 | 0.120 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1293 | 0.120 |
Why?
|
Tissue Adhesions | 2 | 2007 | 222 | 0.120 |
Why?
|
Cyclohexanes | 3 | 2004 | 151 | 0.120 |
Why?
|
Pericytes | 1 | 2018 | 299 | 0.120 |
Why?
|
Colectomy | 1 | 2000 | 697 | 0.120 |
Why?
|
Risk Factors | 9 | 2024 | 74850 | 0.120 |
Why?
|
Vasoconstriction | 2 | 2010 | 593 | 0.120 |
Why?
|
Lipoma | 1 | 2017 | 294 | 0.120 |
Why?
|
History, 20th Century | 4 | 2007 | 2760 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1777 | 0.120 |
Why?
|
Inappropriate Prescribing | 1 | 2017 | 211 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1590 | 0.120 |
Why?
|
Keratosis | 1 | 2015 | 81 | 0.120 |
Why?
|
Pyrazoles | 1 | 2005 | 2031 | 0.120 |
Why?
|
Bone Neoplasms | 1 | 2007 | 2559 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 678 | 0.120 |
Why?
|
Arm | 1 | 2017 | 588 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4563 | 0.110 |
Why?
|
Enzyme Activation | 1 | 2020 | 3583 | 0.110 |
Why?
|
General Surgery | 1 | 2006 | 1722 | 0.110 |
Why?
|
Breast Neoplasms | 4 | 2020 | 21069 | 0.110 |
Why?
|
Ophthalmology | 1 | 2001 | 559 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 646 | 0.110 |
Why?
|
Cells, Cultured | 6 | 2021 | 18962 | 0.110 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2014 | 79 | 0.110 |
Why?
|
Physical Examination | 2 | 2010 | 1263 | 0.110 |
Why?
|
Education, Medical | 1 | 2006 | 1744 | 0.110 |
Why?
|
Pluripotent Stem Cells | 1 | 2021 | 808 | 0.110 |
Why?
|
Tissue Expansion Devices | 1 | 2014 | 159 | 0.110 |
Why?
|
Scrotum | 1 | 2014 | 117 | 0.110 |
Why?
|
Esthetics | 1 | 2015 | 327 | 0.110 |
Why?
|
Random Allocation | 2 | 2010 | 2394 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 4 | 2016 | 2046 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 183 | 0.110 |
Why?
|
Ribs | 1 | 2015 | 254 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2016 | 18292 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 254 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1489 | 0.110 |
Why?
|
Penis | 1 | 2014 | 209 | 0.110 |
Why?
|
Bleomycin | 1 | 2014 | 491 | 0.110 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59496 | 0.110 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1966 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2018 | 22228 | 0.100 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 343 | 0.100 |
Why?
|
Mental Health | 4 | 2017 | 3272 | 0.100 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2012 | 47 | 0.100 |
Why?
|
Sutures | 1 | 2015 | 283 | 0.100 |
Why?
|
Risk Assessment | 5 | 2020 | 24275 | 0.100 |
Why?
|
Computer Simulation | 1 | 2006 | 6251 | 0.100 |
Why?
|
Adipose Tissue | 2 | 2022 | 3314 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4959 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1672 | 0.100 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3928 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1332 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1083 | 0.100 |
Why?
|
Dust | 1 | 2014 | 489 | 0.100 |
Why?
|
Limb Deformities, Congenital | 1 | 2012 | 136 | 0.090 |
Why?
|
Injury Severity Score | 2 | 2012 | 1049 | 0.090 |
Why?
|
Liver | 6 | 2008 | 7559 | 0.090 |
Why?
|
Probability | 2 | 2008 | 2474 | 0.090 |
Why?
|
Comorbidity | 3 | 2019 | 10575 | 0.090 |
Why?
|
Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
Adult Stem Cells | 1 | 2013 | 221 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2014 | 489 | 0.090 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2012 | 156 | 0.090 |
Why?
|
Length of Stay | 3 | 2012 | 6486 | 0.090 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1189 | 0.090 |
Why?
|
Specialization | 1 | 2015 | 779 | 0.090 |
Why?
|
Internship and Residency | 2 | 2008 | 5945 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 678 | 0.090 |
Why?
|
Adipocytes | 1 | 2017 | 1195 | 0.090 |
Why?
|
Polyvinyls | 1 | 2011 | 153 | 0.090 |
Why?
|
Occipital Bone | 1 | 2010 | 55 | 0.090 |
Why?
|
Osteocytes | 1 | 2012 | 193 | 0.090 |
Why?
|
Sampling Studies | 1 | 2011 | 610 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3498 | 0.090 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 371 | 0.090 |
Why?
|
Flow Cytometry | 3 | 2016 | 5880 | 0.090 |
Why?
|
Mice, Inbred C57BL | 9 | 2008 | 22327 | 0.080 |
Why?
|
Retreatment | 1 | 2011 | 598 | 0.080 |
Why?
|
Spain | 2 | 2001 | 483 | 0.080 |
Why?
|
Laser Therapy | 2 | 2015 | 1108 | 0.080 |
Why?
|
Premedication | 1 | 2010 | 245 | 0.080 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 682 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3612 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14643 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 455 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11895 | 0.080 |
Why?
|
Hemostatics | 1 | 2011 | 247 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3661 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7423 | 0.070 |
Why?
|
Crohn Disease | 1 | 2000 | 2281 | 0.070 |
Why?
|
Forehead | 1 | 2008 | 75 | 0.070 |
Why?
|
Intraoperative Care | 1 | 2011 | 768 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 559 | 0.070 |
Why?
|
Models, Animal | 2 | 2011 | 2120 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2470 | 0.070 |
Why?
|
Silicones | 1 | 2008 | 228 | 0.070 |
Why?
|
Homocystinuria | 1 | 2007 | 66 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 619 | 0.070 |
Why?
|
Postoperative Period | 3 | 2015 | 1818 | 0.070 |
Why?
|
Age Factors | 4 | 2012 | 18382 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 512 | 0.070 |
Why?
|
Thoracic Duct | 1 | 2007 | 71 | 0.070 |
Why?
|
Recurrence | 3 | 2020 | 8492 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 2 | 2014 | 1663 | 0.070 |
Why?
|
Perioperative Care | 2 | 2005 | 1042 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 903 | 0.070 |
Why?
|
Particle Size | 1 | 2010 | 1630 | 0.070 |
Why?
|
Chylothorax | 1 | 2007 | 83 | 0.070 |
Why?
|
Melanoma | 3 | 2016 | 5695 | 0.060 |
Why?
|
Administration, Oral | 2 | 2011 | 4016 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.060 |
Why?
|
Paraplegia | 1 | 2006 | 159 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.060 |
Why?
|
Renal Artery Obstruction | 1 | 2007 | 216 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2021 | 11639 | 0.060 |
Why?
|
Picibanil | 1 | 2005 | 10 | 0.060 |
Why?
|
Osteolysis | 1 | 2007 | 271 | 0.060 |
Why?
|
Phospholipase C beta | 2 | 2021 | 48 | 0.060 |
Why?
|
Pressure Ulcer | 1 | 2006 | 158 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10727 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5077 | 0.060 |
Why?
|
Counseling | 2 | 2012 | 1551 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 1009 | 0.060 |
Why?
|
Cellulitis | 1 | 2006 | 206 | 0.060 |
Why?
|
Aortic Coarctation | 1 | 2007 | 278 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6612 | 0.060 |
Why?
|
Electrophoresis | 1 | 2004 | 226 | 0.060 |
Why?
|
Education, Medical, Graduate | 2 | 2008 | 2419 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 36547 | 0.060 |
Why?
|
Dermoid Cyst | 1 | 2005 | 92 | 0.060 |
Why?
|
Eye Infections | 1 | 2005 | 63 | 0.060 |
Why?
|
Spinal Dysraphism | 1 | 2006 | 179 | 0.060 |
Why?
|
Exophthalmos | 1 | 2005 | 100 | 0.060 |
Why?
|
Methacrylates | 1 | 2004 | 109 | 0.050 |
Why?
|
Cerebral Veins | 1 | 2005 | 157 | 0.050 |
Why?
|
Boston | 2 | 2007 | 9334 | 0.050 |
Why?
|
Blepharoptosis | 1 | 2005 | 144 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1685 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4851 | 0.050 |
Why?
|
Neonatal Screening | 1 | 2008 | 619 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6202 | 0.050 |
Why?
|
Facial Nerve | 1 | 2005 | 277 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 20690 | 0.050 |
Why?
|
Poland Syndrome | 1 | 2002 | 14 | 0.050 |
Why?
|
Prospective Studies | 7 | 2014 | 54807 | 0.050 |
Why?
|
Particulate Matter | 1 | 2014 | 2623 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2008 | 1194 | 0.050 |
Why?
|
Microcirculation | 2 | 2008 | 1282 | 0.050 |
Why?
|
Medicine | 1 | 2011 | 944 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1962 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2243 | 0.050 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2007 | 649 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2915 | 0.050 |
Why?
|
Neurofibromatosis 1 | 1 | 2007 | 561 | 0.050 |
Why?
|
Injections | 1 | 2005 | 839 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10810 | 0.050 |
Why?
|
Cell Count | 1 | 2006 | 1823 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3530 | 0.050 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2002 | 122 | 0.050 |
Why?
|
Anastomosis, Surgical | 2 | 2007 | 992 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2016 | 12768 | 0.050 |
Why?
|
Mice, Nude | 2 | 2021 | 3608 | 0.050 |
Why?
|
Pyrroles | 1 | 2007 | 1119 | 0.050 |
Why?
|
Type C Phospholipases | 1 | 2002 | 284 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2002 | 313 | 0.050 |
Why?
|
Vesicular Transport Proteins | 1 | 2024 | 376 | 0.050 |
Why?
|
Osteotomy | 1 | 2006 | 835 | 0.050 |
Why?
|
Safety | 1 | 2005 | 1157 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4481 | 0.050 |
Why?
|
Graft Survival | 1 | 2012 | 3904 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.040 |
Why?
|
PPAR gamma | 1 | 2023 | 484 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2019 | 425 | 0.040 |
Why?
|
Blindness | 1 | 2005 | 587 | 0.040 |
Why?
|
Edema | 1 | 2005 | 759 | 0.040 |
Why?
|
Necrosis | 1 | 2005 | 1611 | 0.040 |
Why?
|
Parenteral Nutrition | 1 | 2005 | 661 | 0.040 |
Why?
|
Surgery, Oral | 1 | 2003 | 133 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3405 | 0.040 |
Why?
|
Patient Care Team | 1 | 2012 | 2515 | 0.040 |
Why?
|
Germany | 1 | 2003 | 882 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4278 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2021 | 187 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1613 | 0.040 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3477 | 0.040 |
Why?
|
Hydrocephalus | 1 | 2006 | 766 | 0.040 |
Why?
|
Biomimetics | 1 | 2021 | 168 | 0.040 |
Why?
|
Needs Assessment | 1 | 2006 | 1140 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9599 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2007 | 857 | 0.040 |
Why?
|
Chondrogenesis | 1 | 2021 | 238 | 0.040 |
Why?
|
Indoles | 1 | 2007 | 1833 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2005 | 802 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4909 | 0.040 |
Why?
|
Hematoma | 1 | 2024 | 765 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16039 | 0.040 |
Why?
|
Frozen Sections | 1 | 1999 | 152 | 0.040 |
Why?
|
Fatty Liver | 1 | 2005 | 810 | 0.040 |
Why?
|
Ilium | 2 | 2011 | 154 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 10611 | 0.040 |
Why?
|
Time Factors | 4 | 2014 | 40097 | 0.040 |
Why?
|
Graft Rejection | 2 | 2007 | 4503 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2022 | 532 | 0.040 |
Why?
|
Tubulin | 1 | 2002 | 693 | 0.040 |
Why?
|
Pneumonectomy | 1 | 2005 | 1128 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 298 | 0.040 |
Why?
|
Massachusetts | 2 | 2014 | 8882 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2006 | 820 | 0.040 |
Why?
|
Vision Disorders | 1 | 2005 | 1085 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12803 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7417 | 0.040 |
Why?
|
Program Evaluation | 1 | 2006 | 2502 | 0.030 |
Why?
|
Isoenzymes | 1 | 2002 | 1688 | 0.030 |
Why?
|
Blotting, Western | 1 | 2004 | 5019 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2021 | 1202 | 0.030 |
Why?
|
Parotid Gland | 1 | 2017 | 177 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2073 | 0.030 |
Why?
|
Quality of Life | 2 | 2015 | 13463 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9525 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2007 | 2077 | 0.030 |
Why?
|
Diplopia | 1 | 2017 | 217 | 0.030 |
Why?
|
Nose | 2 | 2012 | 518 | 0.030 |
Why?
|
Hepatocytes | 1 | 2003 | 1247 | 0.030 |
Why?
|
Respiratory Function Tests | 2 | 2014 | 1692 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10426 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 1985 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13631 | 0.030 |
Why?
|
Databases, Factual | 2 | 2017 | 8060 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14745 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1996 | 255 | 0.030 |
Why?
|
Phlebography | 1 | 2016 | 326 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15401 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 1999 | 453 | 0.030 |
Why?
|
Tyrphostins | 1 | 2014 | 63 | 0.030 |
Why?
|
Craniofacial Dysostosis | 1 | 2014 | 74 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 1996 | 527 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3317 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2021 | 934 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2012 | 5509 | 0.030 |
Why?
|
Acrocephalosyndactylia | 1 | 2014 | 93 | 0.030 |
Why?
|
Seizures | 1 | 2007 | 2997 | 0.030 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 1993 | 22 | 0.030 |
Why?
|
Incidence | 2 | 2012 | 21513 | 0.030 |
Why?
|
Hospital Costs | 1 | 1999 | 955 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2005 | 3447 | 0.030 |
Why?
|
Radioisotope Renography | 1 | 1993 | 61 | 0.030 |
Why?
|
Surgical Wound Infection | 2 | 2015 | 1544 | 0.030 |
Why?
|
Organotechnetium Compounds | 1 | 1993 | 134 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 565 | 0.030 |
Why?
|
Facies | 1 | 2014 | 223 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9373 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2013 | 351 | 0.030 |
Why?
|
Neurology | 1 | 2001 | 784 | 0.030 |
Why?
|
Overweight | 2 | 2015 | 2444 | 0.030 |
Why?
|
Hemorrhage | 1 | 2005 | 3466 | 0.030 |
Why?
|
United States | 2 | 2015 | 72909 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15828 | 0.030 |
Why?
|
Chromogenic Compounds | 1 | 2011 | 29 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1996 | 931 | 0.020 |
Why?
|
Xanthenes | 1 | 2011 | 71 | 0.020 |
Why?
|
Drug Carriers | 1 | 2016 | 701 | 0.020 |
Why?
|
Registries | 1 | 2008 | 8346 | 0.020 |
Why?
|
Chronic Disease | 1 | 2006 | 9351 | 0.020 |
Why?
|
Gene Library | 1 | 2014 | 1066 | 0.020 |
Why?
|
Ice | 1 | 2011 | 102 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3940 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2011 | 456 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2014 | 1336 | 0.020 |
Why?
|
Mosaicism | 1 | 2014 | 481 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 735 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 30230 | 0.020 |
Why?
|
Growth Disorders | 1 | 2014 | 633 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27179 | 0.020 |
Why?
|
School Health Services | 1 | 1993 | 388 | 0.020 |
Why?
|
Oxazines | 1 | 2011 | 358 | 0.020 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 504 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5772 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
Morbidity | 1 | 2014 | 1752 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 701 | 0.020 |
Why?
|
Microvessels | 1 | 2013 | 590 | 0.020 |
Why?
|
North America | 1 | 2012 | 1287 | 0.020 |
Why?
|
Rhinoplasty | 1 | 2012 | 241 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2014 | 781 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1964 | 0.020 |
Why?
|
Radiography | 2 | 2014 | 6941 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2036 | 0.020 |
Why?
|
Abdominal Cavity | 1 | 2007 | 33 | 0.020 |
Why?
|
Cold Temperature | 1 | 2011 | 793 | 0.020 |
Why?
|
Drug Combinations | 2 | 2011 | 2075 | 0.020 |
Why?
|
Oligopeptides | 1 | 1993 | 1193 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1319 | 0.020 |
Why?
|
Cell Separation | 1 | 2013 | 1718 | 0.020 |
Why?
|
Sirolimus | 1 | 2014 | 1541 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 1990 | 316 | 0.020 |
Why?
|
Postoperative Care | 2 | 2010 | 1475 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2014 | 1429 | 0.020 |
Why?
|
Apoptosis | 1 | 2003 | 9505 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2013 | 1494 | 0.020 |
Why?
|
Lung | 1 | 2005 | 10046 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5531 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6491 | 0.020 |
Why?
|
Lidocaine | 1 | 1990 | 545 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2008 | 268 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 527 | 0.020 |
Why?
|
Fetal Blood | 1 | 2013 | 1365 | 0.020 |
Why?
|
Amputation, Traumatic | 1 | 2007 | 135 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2350 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 347 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2007 | 748 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4466 | 0.020 |
Why?
|
Nasal Bone | 1 | 2005 | 58 | 0.020 |
Why?
|
Heart Function Tests | 1 | 1986 | 317 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2008 | 483 | 0.010 |
Why?
|
Absorbable Implants | 1 | 2007 | 333 | 0.010 |
Why?
|
Temperature | 1 | 2011 | 2226 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5873 | 0.010 |
Why?
|
Health Surveys | 1 | 2014 | 4058 | 0.010 |
Why?
|
Titanium | 1 | 2007 | 490 | 0.010 |
Why?
|
Surgical Mesh | 1 | 2007 | 315 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1695 | 0.010 |
Why?
|
Bone Plates | 1 | 2007 | 468 | 0.010 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1986 | 239 | 0.010 |
Why?
|
Skull Base | 1 | 2007 | 293 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2005 | 9065 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3430 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4037 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8279 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2007 | 723 | 0.010 |
Why?
|
Myocardium | 1 | 1996 | 4764 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1990 | 1004 | 0.010 |
Why?
|
Heart | 1 | 1996 | 4419 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2014 | 3209 | 0.010 |
Why?
|
Spodoptera | 1 | 2002 | 140 | 0.010 |
Why?
|
Cholinergic Agonists | 1 | 2002 | 75 | 0.010 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 325 | 0.010 |
Why?
|
Chick Embryo | 1 | 2004 | 964 | 0.010 |
Why?
|
Azides | 1 | 2002 | 120 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2010 | 1359 | 0.010 |
Why?
|
Microsurgery | 1 | 2007 | 798 | 0.010 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 94 | 0.010 |
Why?
|
Carbachol | 1 | 2002 | 223 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5738 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 812 | 0.010 |
Why?
|
Hydrolysis | 1 | 2002 | 643 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3801 | 0.010 |
Why?
|
Molecular Structure | 1 | 2004 | 1880 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 2196 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2729 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 839 | 0.010 |
Why?
|
Mice, SCID | 1 | 2004 | 2626 | 0.010 |
Why?
|
Exercise | 1 | 2015 | 5936 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1993 | 4277 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3225 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7073 | 0.010 |
Why?
|
Dietary Fats | 1 | 2005 | 2002 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2004 | 1037 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3716 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2713 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4627 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 3599 | 0.010 |
Why?
|
Antigens, CD | 1 | 2007 | 4023 | 0.010 |
Why?
|
Polymers | 1 | 2004 | 1622 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4342 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2062 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7473 | 0.010 |
Why?
|
Dihydropyridines | 1 | 1996 | 66 | 0.010 |
Why?
|
Thymidine | 1 | 1996 | 294 | 0.010 |
Why?
|
Lac Operon | 1 | 1996 | 237 | 0.010 |
Why?
|
Thermosensing | 1 | 1996 | 56 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1996 | 315 | 0.010 |
Why?
|
Receptors, Thrombin | 1 | 1996 | 130 | 0.010 |
Why?
|
Tritium | 1 | 1996 | 702 | 0.010 |
Why?
|
Peptides | 1 | 2007 | 4331 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15540 | 0.010 |
Why?
|
Weight Gain | 1 | 2005 | 2356 | 0.010 |
Why?
|
Regeneration | 1 | 2004 | 1516 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6209 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 1996 | 924 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3733 | 0.010 |
Why?
|
Carcinoma | 1 | 2004 | 2311 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 3635 | 0.010 |
Why?
|
Rhode Island | 1 | 1993 | 351 | 0.010 |
Why?
|
Calcium Channels | 1 | 1996 | 622 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26282 | 0.010 |
Why?
|
Tetracaine | 1 | 1990 | 34 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8924 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9296 | 0.010 |
Why?
|
Echocardiography | 1 | 2002 | 5040 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1996 | 1109 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 1990 | 215 | 0.000 |
Why?
|
Administration, Topical | 1 | 1990 | 702 | 0.000 |
Why?
|
Wound Infection | 1 | 1990 | 244 | 0.000 |
Why?
|
Risk-Taking | 1 | 1993 | 1021 | 0.000 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 1986 | 15 | 0.000 |
Why?
|
Functional Residual Capacity | 1 | 1986 | 70 | 0.000 |
Why?
|
Urban Population | 1 | 1993 | 2040 | 0.000 |
Why?
|
Cocaine | 1 | 1990 | 944 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5784 | 0.000 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1993 | 2204 | 0.000 |
Why?
|
Data Collection | 1 | 1993 | 3318 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1986 | 744 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1993 | 2192 | 0.000 |
Why?
|
Calcium | 1 | 1996 | 5769 | 0.000 |
Why?
|
Carbon Monoxide | 1 | 1986 | 560 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23708 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2004 | 13446 | 0.000 |
Why?
|
Patient Acceptance of Health Care | 1 | 1990 | 3230 | 0.000 |
Why?
|